Squarepoint’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
220,853
+29,680
+16% +$249K ﹤0.01% 2178
2025
Q4
$1.42M Buy
191,173
+43,493
+29% +$313K ﹤0.01% 2318
2025
Q3
$988K Buy
147,680
+39,628
+37% +$275K ﹤0.01% 2704
2025
Q2
$715K Buy
108,052
+64,459
+148% +$457K ﹤0.01% 2951
2025
Q1
$399K Buy
+43,593
New +$435K ﹤0.01% 3501
2024
Q4
Sell
-30,154
Closed -$360K 5051
2024
Q3
$360K Buy
30,154
+3,983
+15% +$34.4K ﹤0.01% 3328
2024
Q2
$150K Buy
26,171
+3,170
+14% +$17.4K ﹤0.01% 3726
2024
Q1
$120K Buy
+23,001
New +$112K ﹤0.01% 3764
2023
Q1
Sell
-65,057
Closed -$170K 3259
2022
Q4
$170K Buy
+65,057
New +$284K ﹤0.01% 2837
2022
Q1
Sell
-13,271
Closed -$192K 2865
2021
Q4
$192K Buy
+13,271
New +$189K ﹤0.01% 2721

Other funds holding BVS